Bio-Oriented Synthesis and Molecular Docking Studies of 1,2,4-Triazole Based Derivatives as Potential Anti-Cancer Agents against HepG2 Cell Line

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt


  • Fulltext

    Forlagets udgivne version, 4,17 MB, PDF-dokument

  • Naheed Akhter
  • Sidra Batool
  • Samreen Gul Khan
  • Nasir Rasool
  • Fozia Anjum
  • Azhar Rasul
  • Sevki Adem
  • Sadaf Mahmood
  • Aziz ur Rehman
  • Mehr un Nisa
  • Zainib Razzaq
  • Christensen, Jørn Bolstad
  • Mohammed A. S. Abourehab
  • Syed Adnan Ali Shah
  • Syahrul Imran

Triazole-based acetamides serve as important scaffolds for various pharmacologically active drugs. In the present work, structural hybrids of 1,2,4-triazole and acetamides were furnished by chemically modifying 2-(4-isobutylphenyl) propanoic acid (1). Target compounds 7a-f were produced in considerable yields (70-76%) by coupling the triazole of compound 1 with different electrophiles under different reaction conditions. These triazole-coupled acetamide derivatives were verified by physiochemical and spectroscopic (HRMS, FTIR, (CNMR)-C-13, and (HNMR)-H-1,) methods. The anti-liver carcinoma effects of all of the derivatives against a HepG2 cell line were investigated. Compound 7f, with two methyl moieties at the ortho-position, exhibited the highest anti-proliferative activity among all of the compounds with an IC50 value of 16.782 mu g/mL. 7f, the most effective anti-cancer molecule, also had a very low toxicity of 1.190.02%. Molecular docking demonstrates that all of the compounds, especially 7f, have exhibited excellent binding affinities of -176.749 kcal/mol and -170.066 kcal/mol to c-kit tyrosine kinase and protein kinase B, respectively. Compound 7f is recognized as the most suitable drug pharmacophore for the treatment of hepatocellular carcinoma.

Udgave nummer2
Antal sider18
StatusUdgivet - 2023

Antal downloads er baseret på statistik fra Google Scholar og

Ingen data tilgængelig

ID: 338943354